Journal
PEDIATRIC HEMATOLOGY AND ONCOLOGY
Volume 22, Issue 4, Pages 277-284Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/08880010590935167
Keywords
antibiotics; febrile neutropenia; immunosuppression; infection; meropenem
Categories
Ask authors/readers for more resources
The aim of this retrospective study was to evaluate the clinical effectiveness of meropenem in immunocompromised children. Between January 1998 and December 2002 in the hemato-oncological units Of our hospital meropenem was used in 87 febrile events diagnosed in 55 patients, and 328 bacterial cultures were evaluated. Microorganisms were detected and identified in 64 of the 328 hemocultures there was a predominance (67%). In, 49.4% the infection was documented microbiologically. In 16 additional cases the infection was proven clinically and 32.2% of the episodes were considered to be fever of unknown origin. The success rate of the meropenem therapy-excluding the proven fungal or coagulase-negative Staphylococcus infections-was 72.9% and for the Whole cohort 49.4%. The results demonstrate that meropenem. is effective and well-tolerated when used for the treatment of neutropenic cancer children.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available